Loading clinical trials...
Loading clinical trials...
Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multi-Center Study
Conditions
Interventions
Quantiferon-CMV assay
Locations
6
Canada
University of Alberta Hospital
Edmonton, Alberta, Canada
St. Paul's Hospital - Providence Health
Vancouver, British Columbia, Canada
London Health Sciences Centre
London, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
University Health Network, Toronto General Hospital
Toronto, Ontario, Canada
Hospital Universitario 12 de Octubre
Madrid, Spain
Start Date
June 1, 2016
Primary Completion Date
February 1, 2020
Completion Date
April 1, 2020
Last Updated
August 2, 2022
Lead Sponsor
University Health Network, Toronto
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions